Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study

References

• Eckhardt S. Recent progress in the development of anticancer agents. Curr Med Chem Anticancer Agents 2002;2:419–39.
   PubMedGoogle Scholar
• Avendańo C, Menéndez J. Medicinal chemistry of anticancer agents. Amsterdam: Elsevier; 2008.
   Google Scholar
• Varmus H. The new era in cancer research. Science 2006;312:1162–5.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Alaa A-M, Al-Suwaidan IA, et al. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Eur J Med Chem 2014;79:446–54.
   PubMed Web of Science ®Google Scholar
• Al-Suwaidan IA, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4 (3H) quinazolinone analogues. J Enzyme Inhib Med Chem 2016;31:78–89.
   PubMed Web of Science ®Google Scholar
• Mohamed MA, Ayyad RR, Shawer TZ, et al. Synthesis and antitumor evaluation of trimethoxyanilides based on 4 (3H)-quinazolinone scaffolds. Eur J Med Chem 2016;112:106–13.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Al-Suwaidan IA, Alaa A-M, et al. Design, synthesis and biological evaluation of some novel substituted 2-mercapto-3-phenethylquinazolines as antitumor agents. Med Chem Res 2013;22:5566–77.
   Web of Science ®Google Scholar
• Abdel-Aziz AA, El-Azab AS, Alanazi AM, et al. Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies. J Enzyme Inhib Med Chem 2016;31:796–809.
   PubMed Web of Science ®Google Scholar
• Al-Suwaidan IA, Alanazi AM, Abdel-Aziz AA, et al. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study. Bioorg Med Chem Lett 2013;23:3935–41.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Abdel-Aziz AA, Shawer TZ, et al. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. J Enzyme Inhib Med Chem 2016;31:721–35.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz AA, El-Azab AS, El-Subbagh HI, et al. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones. Bioorg Med Chem Lett 2012;22:2008–14.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, Al-Omar MA, Alaa A-M, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem 2010;45:4188–98.
   PubMed Web of Science ®Google Scholar
• Djordjevic VB. Free radicals in cell biology. Int Rev Cytol 2004;237:57–89.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008;52:S128–S38.
   PubMed Web of Science ®Google Scholar
• Birben E, Sahiner UM, Sackesen C, et al. Oxidative stress and antioxidant defense. World Allergy Organ J 2012;5:9–19.
   PubMedGoogle Scholar
• Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915–22.
   PubMed Web of Science ®Google Scholar
• Mut-Salud N, Alvarez PJ, Garrido JM, et al. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results. Oxid Med Cell Longev 2016;2016:6719534.
   PubMed Web of Science ®Google Scholar
• Joseph A, Shah CS, Kumar SS, et al. Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones. Acta Pharm 2013;63:397–408.
   PubMed Web of Science ®Google Scholar
• Danciu C, Vlaia L, Fetea F, et al. Evaluation of phenolic profile, antioxidant and anticancer potential of two main representants of Zingiberaceae family against B164A5 murine melanoma cells. Biol Res 2015;48:1.
   PubMed Web of Science ®Google Scholar
• Khaledi H, Alhadi AA, Yehye WA, et al. Antioxidant, cytotoxic activities, and structure-activity relationship of gallic acid-based indole derivatives. Arch Pharm (Weinheim) 2011;344:703–9.
   PubMed Web of Science ®Google Scholar
• Kodisundaram P, Duraikannu A, Balasankar T, et al. Cytotoxic and antioxidant activity of a set of hetero bicylic methylthiadiazole hydrazones: a structure-activity study. Int J Mol Cell Med 2015;4:128–37.
   PubMed Web of Science ®Google Scholar
• Bayomi SM, El-Kashef HA, El-Ashmawy MB, et al. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study. Eur J Med Chem 2015;101:584–94.
   PubMed Web of Science ®Google Scholar
• Manojkumar P, Ravi TK, Subbuchettiar G. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells. Acta Pharm 2009;59:159–70.
   PubMed Web of Science ®Google Scholar
• Bazley LA, Gullick WJ. The epidermal growth factor receptor family. Endocr Relat Cancer 2005;12(Suppl 1):S17–S27.
   PubMed Web of Science ®Google Scholar
• Bishayee S. Role of conformational alteration in the epidermal growth factor receptor (EGFR) function. Biochem Pharmacol 2000;60:1217–23.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Varella-Garcia M, Bunn PA Jr. et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003;21:3798–807.
   PubMed Web of Science ®Google Scholar
• Ogiso H, Ishitani R, Nureki O, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002;110:775–87.
   PubMed Web of Science ®Google Scholar
• Ivankovic M, Cukusic A, Gotic I, et al. Telomerase activity in HeLa cervical carcinoma cell line proliferation. Biogerontology 2007;8:163–72.
   PubMed Web of Science ®Google Scholar
• Zhang X, Mar V, Zhou W, et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 1999;13:2388–99.
   PubMed Web of Science ®Google Scholar
• Wei G, Cui S, Luan W, et al. Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death. Eur J Med Chem 2016;113:92–101.
   PubMed Web of Science ®Google Scholar
• Umekita Y, Ohi Y, Sagara Y, Yoshida H. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. Int J Cancer 2000;89:484–7.
   PubMed Web of Science ®Google Scholar
• Ganjoo KN, Wakelee H. Review of erlotinib in the treatment of advanced non-small cell lung cancer. Biologics 2007;1:335–46.
   PubMedGoogle Scholar
• Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002;277:46265–72.
   PubMed Web of Science ®Google Scholar
• Minami Y, Shimamura T, Shah K, et al. The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. Oncogene 2007;26:5023–7.
   PubMed Web of Science ®Google Scholar
• Rabindran SK, Discafani CM, Rosfjord EC, et al. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Res 2004;64:3958–65.
   PubMed Web of Science ®Google Scholar
• Wissner A, Mansour TS. The development of HKI-272 and related compounds for the treatment of cancer. Arch Pharm (Weinheim) 2008;341:465–77.
   PubMed Web of Science ®Google Scholar
• Morgillo F, Martinelli E, Troiani T, et al. Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. PLoS One 2011;6:e28841.
   PubMed Web of Science ®Google Scholar
• Yamaguchi N, Lucena-Araujo AR, Nakayama S, et al. Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer. Lung Cancer 2014;83:37–43.
   PubMed Web of Science ®Google Scholar
• Yasuda H, de Figueiredo-Pontes LL, Kobayashi S, Costa DB. Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer. J Thorac Oncol 2012;7:1086–90.
   PubMed Web of Science ®Google Scholar
• Ou SH. Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond. Drug Des Devel Ther 2011;5:471–85.
   PubMed Web of Science ®Google Scholar
• Youssef KM, El-Sherbeny MA, El-Shafie FS, et al. Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents. Arch Pharm (Weinheim) 2004;337:42–54.
   PubMed Web of Science ®Google Scholar
• Sokmen M, Akram Khan M. The antioxidant activity of some curcuminoids and chalcones. Inflammopharmacology 2016;24:81–6.
   PubMed Web of Science ®Google Scholar
• Bayomi SM, El-Kashef HA, El-Ashmawy MB, et al. Synthesis and biological evaluation of new curcumin derivatives as antioxidant and antitumor agents. Med Chem Res 2013;22:1147–62.
   Web of Science ®Google Scholar
• Katsori AM, Hadjipavlou-Litina D. Chalcones in cancer: understanding their role in terms of QSAR. Curr Med Chem 2009;16:1062–81.
   PubMed Web of Science ®Google Scholar
• Karthikeyan C, Moorthy NS, Ramasamy S, et al. Advances in chalcones with anticancer activities. Recent Pat Anticancer Drug Discov 2015;10:97–115.
   PubMed Web of Science ®Google Scholar
• Syam S, Abdelwahab SI, Al-Mamary MA, Mohan S. Synthesis of chalcones with anticancer activities. Molecules 2012;17:6179–95.
   PubMed Web of Science ®Google Scholar
• Jung SK, Lee MH, Lim DY, et al. Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. J Biol Chem 2014;289:35839–48.
   PubMed Web of Science ®Google Scholar
• Xu YY, Cao Y, Ma H, et al. Design, synthesis and molecular docking of alpha,beta-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. Bioorg Med Chem 2013;21:388–94.
   PubMed Web of Science ®Google Scholar
• Alswah M, Bayoumi AH, Elgamal K, et al. Design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo[4,3-a]-quinoxaline moieties as potent anticancer agents with dual EGFR kinase and tubulin polymerization inhibitory effects. Molecules 2017;23:E48. DOI:10.3390/molecules23010048
   PubMed Web of Science ®Google Scholar
• Lee JY, Lee YM, Chang GC, et al. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PLoS One 2011;6:e23756.
   PubMed Web of Science ®Google Scholar
• Wada K, Lee JY, Hung HY, et al. Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. Bioorg Med Chem 2015;23:1507–14.
   PubMed Web of Science ®Google Scholar
• Starok M, Preira P, Vayssade M, et al. EGFR inhibition by curcumin in cancer cells: a dual mode of action. Biomacromolecules 2015;16:1634–42.
   PubMed Web of Science ®Google Scholar
• Qin HL, Leng J, Youssif BGM, et al. Synthesis and mechanistic studies of curcumin analog-based oximes as potential anticancer agents. Chem Biol Drug Des 2017;90:443–9.
   PubMed Web of Science ®Google Scholar
• Li QS, Lv XH, Zhang YB, et al. Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents. Bioorg Med Chem Lett 2012;22:6596–601.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Zhang H, Sun J, et al. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. Bioorg Med Chem 2012;20:6089–96.
   PubMed Web of Science ®Google Scholar
• Kaur N, Kishore D. Application of chalcones in heterocycles synthesis: synthesis of 2-(isoxazolo, pyrazolo and pyrimido) substituted analogues of 1, 4-benzodiazepin-5-carboxamides linked through an oxyphenyl bridge. J Chem Sci 2013;125:555–60.
   Web of Science ®Google Scholar
• Samshuddin S, Narayana B, Sarojini B, et al. Synthesis, characterization and biological evaluation of functionalized derivatives of versatile synthon 4, 4'-difluoro chalcone. Der Pharma Chemica 2012;4:1445–7.
   Google Scholar
• Bingul M, Tan O, Gardner CR, et al. Synthesis, characterization and anti-cancer activity of hydrazide derivatives incorporating a quinoline moiety. Molecules 2016;21:916. DOI:10.3390/molecules21070916
   PubMed Web of Science ®Google Scholar
• Sangani CB, Makawana JA, Zhang X, et al. Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents. Eur J Med Chem 2014;76:549–57.
   PubMed Web of Science ®Google Scholar
• Lv PC, Li DD, Li QS, et al. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Bioorg Med Chem Lett 2011;21:5374–7.
   PubMed Web of Science ®Google Scholar
• Demnitz J, LaVecchia L, Bacher E, et al. Enantiodivergent synthesis of (R)-and (S)-rolipram. Molecules 1998;3:107–19.
   Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271–7.
   PubMed Web of Science ®Google Scholar
• Hsu CF, Peng H, Basle C, et al. ABTS•+ scavenging activity of polypyrrole, polyaniline and poly (3, 4‐ethylenedioxythiophene). Polym Int 2011;60:69–77.
   Web of Science ®Google Scholar
• Lissi EA, Modak B, Torres R, et al. Total antioxidant potential of resinous exudates from Heliotropium species, and a comparison of the ABTS and DPPH methods. Free Radic Res 1999;30:471–7.
   PubMed Web of Science ®Google Scholar
• Available from: http://www.abcam.com/human-egfr-in-cell-elisa-kit-ab126419.html [last accessed 15 Dec 2017].
   Google Scholar
• MOE 200810 of Chemical Computing Group Inc. Available from: http://www.chemcomp.com/ [last accessed 1 Jun 2017].
   Google Scholar
• El-Azab AS, Abdel-Aziz AA, Ghabbour HA, Al-Gendy MA. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues. J Enzyme Inhib Med Chem 2017;32:1229–39.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, Al-Dhfyan A, Abdel-Aziz AA, et al. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies. J Enzyme Inhib Med Chem 2017;32:935–44.
   PubMed Web of Science ®Google Scholar
• El-Sayed MA, El-Husseiny WM, Abdel-Aziz NI, et al. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study. J Enzyme Inhib Med Chem 2018;33:199–209.
   PubMed Web of Science ®Google Scholar
• Lv Q, Fang L, Wang P, et al. A simple one-pot synthesis of quinoline-4-carboxylic acid derivatives by Pfitzinger reaction of isatin with ketones in water. Monatshefte Chemie-Chemical Monthly 2013;144:391–4.
   Google Scholar
• Vega-Avila E, Pugsley MK. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc 2011;54:10–14.
   PubMedGoogle Scholar
• Available from: http://www.sigmaplot.co.uk/products/sigmaplot/sigmaplot-details.php [last accessed 1 Jul 2017].
   Google Scholar